Futures on the S&P 500 are snapping a week‑long winning streak, falling nearly 1.2 % at the start of trading. Moody’s cut to the U.S. credit rating has revived a “sell‑America” mood — equities are sliding while rising Treasury yields spotlight the cost of servicing U.S. debt.
Since 22 April U.S. indices had been clawing back two months of losses triggered by fresh rounds of Donald Trump’s trade‑war tariffs. The US500 closed last week at the doorstep of the psychological 6 000 mark, brushing overbought territory (RSI > 70). Source: xStation5
For years debt was America’s chief export, and an enduring faith in U.S. exceptionalism and economic efficiency let the country summon record amounts of capital. That landscape may be shifting after Moody’s—the last of the three big agencies (alongside S&P and Fitch)—downgraded the United States. Moody’s reasoning echoes the themes Donald Trump campaigned on in 2024.
The focus is the relentlessly rising federal debt. From 2012 to 2024 the debt‑to‑GDP ratio climbed from 70 % to 98 %, and neither party has offered lasting measures to halt the debt spiral. Servicing costs are also swelling, as reflected in higher Treasury yields. Moody’s notes that interest on federal debt consumed 18 % of revenue in 2024, up from 9 % in 2021.
Although President Trump has called for debt reduction since the campaign, his administration’s actions—and Moody’s projections—do not point to quick progress. The 2025 budget shortfall is nearly $210 billion larger than in 2024, and the planned tax cuts may not be fully covered by tariffs given the drive to de‑escalate the trade war. Cuts to social programs pencilled in for 2026 would trim federal spending by only about 15 %, leaving the biggest outlays (e.g., Medicare and interest payments) largely intact. Despite Trump’s agenda, Moody’s forecasts U.S. debt will reach 134 % of GDP before 2035.
The United States has exited the club of top‑rated sovereign borrowers. Note, however, that most economies still rated AAA are themselves under review for possible status changes (“u” = under review). Source: Bloomberg Finance L.P.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
